Neuroprotective effects of Caffeic acid phenethyl ester administered with levodopa and benserazide in a rat model of Parkinson’s disease
Open Access
- 1 September 2025
- journal article
- Published by National Academy of Sciences of Tajikistan in Physiology and Pharmacology
- Vol. 29 (3) , 272-283
Abstract
Introduction: Parkinson’s disease (PD) is a neurological disorder caused by the pathological destruction of dopaminergic neurons. Although it is commonly associated with motor symptoms, most patients also experience a range of non-motor symptoms, including mental health issues such as anxiety, depression, and memory loss. In this study, we investigated the effect of ...Keywords
This publication has 33 references indexed in Scilit:
- The relationship between the distinct ratios of benserazide and carbidopa to levodopa and motor complications in Parkinson's disease: A retrospective cohort studyJournal of the Neurological Sciences, 2022
- Comparison of pramipexole and levodopa/benserazide combination therapy versus levodopa/benserazide monotherapy in the treatment of Parkinson’s disease: a systematic review and meta-analysisNaunyn-Schmiedeberg's Archives of Pharmacology, 2021
- Caffeic acid improves locomotor activity and lessens inflammatory burden in a mouse model of rotenone-induced nigral neurodegeneration: Relevance to Parkinson’s disease therapyPharmacological Reports, 2019
- Mesolimbic dopamine system and its modulation by vitamin D in a chronic mild stress model of depression in the ratBehavioural Brain Research, 2019
- Chlorpyrifos-induced parkinsonian model in mice: Behavior, histopathology and biochemistryPesticide Biochemistry and Physiology, 2018
- Effects of moderate treadmill exercise and fluoxetine on behavioural and cognitive deficits, hypothalamic-pituitary-adrenal axis dysfunction and alternations in hippocampal BDNF and mRNA expression of apoptosis – related proteins in a rat model of post-traumatic stress disorderNeurobiology of Learning and Memory, 2017
- Potential mechanisms underlying anxiety and depression in Parkinson's disease: Consequences of l-DOPA treatmentNeuroscience & Biobehavioral Reviews, 2011
- Caffeic acid improves the bioavailability of l‐dopa in rabbit plasmaPhytotherapy Research, 2010
- Caffeic acid phenethyl ester suppresses oxidative stress in Escherichia coli-induced pyelonephritis in ratsMolecular and Cellular Biochemistry, 2006
- Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's diseaseJournal of Neuroscience Methods, 2005